TD Cowen downgraded PhenomeX (CELL) to Market Perform from Outperform with a $1 price target, citing Bruker’s (BRKR) plans to acquire the company.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CELL:
- PhenomeX downgraded to Hold from Buy at Berenberg
- PhenomeX upgraded to Equal Weight from Underweight at Morgan Stanley
- Berkeley Lights trading resumes
- Bruker to acquire PhenomeX for $1.00 per share
- Berkeley Lights trading halted, news pending
Questions or Comments about the article? Write to editor@tipranks.com